Cargando…

Mechanisms for increased healthcare expenditures among patients with device detected atrial fibrillation

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: There are limited data on the mechanisms of increased healthcare costs among patients with atrial fibrillation (AF). Differences in healthcare expenditures at various sites of service may provide mechanistic insight into the cost d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peigh, G, Zhou, J, Roberts, A I, Rosemas, S C, Longacre, C, Schwab, G, Soderlund, D, Passman, R S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	10.2 - Epidemiology, Prognosis, Outcome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207251/ http://dx.doi.org/10.1093/europace/euad122.020

Ejemplares similares

Association between atrial fibrillation and healthcare costs among patients with cardiac implantable electronic devices
por: Peigh, G, et al.
Publicado: (2023)

Atrial fibrillation diagnosis in patients with single- and dual chamber ICD devices in England: a real-world cohort study
por: Davidson, J A, et al.
Publicado: (2023)

Impact of pulmonary vein anatomy and ostial dimensions on long term outcome after single-shot device guided cryoablation for paroxysmal atrial fibrillation
por: Isgandarova, K, et al.
Publicado: (2023)

Lower atrial fibrillation recurrence after ablation in general anesthesia - a danish nationwide registry study
por: Riis-Vestergaard, L, et al.
Publicado: (2023)

Left atrial strain significance in prediction of early atrial fibrillation recurrence after cardioversion and ablation
por: Sabanovic-Bajramovic, N, et al.
Publicado: (2023)

Disease awareness and knowledge of stroke- and atrial fibrillation risk factors in cardiovascular patients
por: Engler, D, et al.
Publicado: (2023)

The role of education level in the mortality of hospitalized patients with atrial fibrillation
por: Sztaniszlav, A, et al.
Publicado: (2023)

Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients
por: Fawzy, A M, et al.
Publicado: (2023)

Number of comorbidities is associated with symptom severity and arrhythmia progression in paroxysmal atrial fibrillation - Data from the RACE V study
por: Van De Lande, M E, et al.
Publicado: (2023)

5 years incident stroke, heart failure, acute myocardial infarction, and death in patients having undergone atrial fibrillation ablation according to BMI
por: Toennesen, J, et al.
Publicado: (2023)

Predictors and outcomes of late atrial fibrillation following coronary artery bypass grafting
por: Jameie, M, et al.
Publicado: (2023)

New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring
por: Kawczynski, M, et al.
Publicado: (2023)

Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant
por: Lee, S R, et al.
Publicado: (2023)

Temporal relation of disease onsets in patients with acute myocardial infarction and atrial fibrillation - results from a nationwide registry study
por: Karlsson, E, et al.
Publicado: (2023)

Timing of clinically relevant recurrence or true blanking period?
por: Mendsaikhan, P, et al.
Publicado: (2023)

Age and genetics are associated with ventricular fibrillation but not with monomorphic ventricular tachycardia in Brugada syndrome
por: Pannone, L, et al.
Publicado: (2023)

Long-term follow-up of idiopathic ventricular fibrillation: A 30-year experience from our hospital
por: Rattanawong, P, et al.
Publicado: (2023)

Catheter ablation of left atrial tachyarrhythmia: predictors of recurrence after catheter ablation
por: Marazzato, J, et al.
Publicado: (2023)

Cardiac implantable electronic devices and outcomes in heart failure patients with syncope
por: Rattanawong, P, et al.
Publicado: (2023)

Genetic testing in children with Brugada syndrome: results from a large prospective registry
por: Pannone, L, et al.
Publicado: (2023)

The impact of nationwide lockdown on acute coronary syndromes hospitalization rate in the Western Macedonia regional hospital of Greece
por: Kanellos, I, et al.
Publicado: (2021)

Syncope in patients with diagnosed with hypertrophic cardiomyopathy: risk of ventricular tachycardia, cardiac arrest and death
por: Zoerner, C R, et al.
Publicado: (2023)

Ventricular tachycardia predicts all-cause mortality and non-sudden cardiac death in non-ischaemic cardiomyopathy
por: Omara, S, et al.
Publicado: (2023)

Incidence and predictors of new-onset sustained ventricular tachycardia in patients with cardiac sarcoidosis and high-grade AV block as first cardiac symptom
por: Dinov, B, et al.
Publicado: (2023)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
por: Weerts, J, et al.
Publicado: (2023)

Non-revascularized chronic total occlusion is associated with worse outcomes in post-MI drug-refractory electrical storm patients treated by catheter ablation
por: Cojocaru, C, et al.
Publicado: (2023)

Acute coronary syndrome in COVID-19 patients. Clinical features, severity and outcomes. Results from Spanish multicenter registry Car-COVID19
por: Abellas Sequeiros, M, et al.
Publicado: (2021)

Left ventricular hypertrophy, dilatation and ejection fractions predict ventricular tachycardia in amyloid transthyretin cardiomyopathy
por: Knoll, K, et al.
Publicado: (2023)

The long-term outcome of malignant outflow tract ventricular tachycardia in patients without structural heart disease
por: Kim, Y R, et al.
Publicado: (2023)

Familial predisposition to cardiovascular disease and death in patients with an out-of-hospital cardiac arrest
por: Gylling, M, et al.
Publicado: (2023)

Acute coronary syndrome in COVID-19 times: could it be business as usual?
por: Ferreira, J, et al.
Publicado: (2021)

Ventricular tachycardia substrate ablation in patients with slightly depressed left ventricular ejection fraction. Predictors of VT-free survival in a prospective multicentre registry
por: Falasconi, G, et al.
Publicado: (2023)

Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort
por: Seganti, A, et al.
Publicado: (2023)

Ventricular conduction is a marker for arrhythmic risk in overlap sodium channel disease
por: Wijeyeratne, Y, et al.
Publicado: (2023)

Using the 3D architecture of scar to predict life-threatening ventricular arrythmias - still a long way to go
por: Amador, R, et al.
Publicado: (2023)

Impact of the covid pandemic on admission for acute heart disease in a level II coronary unit
por: Campos Pareja, AM, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on admissions and management of acute coronary syndrome: a single tertiary cardiac centre experience in the United Kingdom
por: Tomson, J, et al.
Publicado: (2021)

A focus on pregnancy course and outcomes in women with complete atrioventricular block: a single center experience
por: Abdrakhmanov, A, et al.
Publicado: (2023)

Sinus rate and QRS duration on lead V1 predict major events in Brugada syndrome
por: Laporte, P, et al.
Publicado: (2023)

Incidence and autopsy rates of sudden cardiac death in Northern Finland
por: Mantyniemi, L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3h06253eqp5lu4inu92e4jcp7b